Legal Representation
Attorney
Matthew A. Homyk
USPTO Deadlines
Next Deadline
398 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-01)
Due Date
September 01, 2026
Grace Period Ends
March 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 1, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 16, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 16, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 27, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 11, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 30, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 30, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 30, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2020 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 29, 2020 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 29, 2020 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 11, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 10, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 10, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Class 040
Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Class 042
Development of pharmaceutical preparations and medicines
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Additional Information
Design Mark
The mark consists of four rounded bars converging at the center at ninety-degree angles, each separated perpendicularly by circles in the spaces between the bars.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
040
042